Last update:
Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome
The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The ...
2 hours ago
0
4
Medical research news
Reversing immune suppression in pancreatic cancer could lead to novel therapies
In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer cells send out tiny particles that are packed with certain microRNA molecules, nearby immune cells ...
3 hours ago
0
0
1 in 5 people say losing their pet was worse than losing a person
For one in five people, losing a pet has been more distressing than losing a human loved one. New research has revealed that 21% of those who experienced both types of bereavement found their pet's death harder to bear.
8 hours ago
0
54
Super agers tend to have at least two key genetic advantages, study finds
The gene variant posing the greatest genetic risk of late-onset Alzheimer's disease (AD) is called APOE-ε4. A different variant of the same gene, APOE-ε2, is thought to confer protection against AD.
9 hours ago
0
32
Molecular 'switch' that turns on inflammation in obesity points to new therapeutic targets
A team led by UT Southwestern Medical Center researchers has uncovered a molecular pathway that links obesity to widespread inflammation, providing long-sought insight into why obesity increases the risk of type 2 diabetes, ...
9 hours ago
0
0
Decline in U.S. nursing home capacity since COVID-19: Rural areas hit hardest
Though the U.S. population is aging, nursing home capacity has declined nationwide since the COVID-19 pandemic began. According to a study published in JAMA Internal Medicine this week, one quarter of U.S. counties experienced ...
8 hours ago
0
38
Ion channel offers promising avenue for new Parkinson's drugs
Lysosomes are the recycling centers of human cells. Larger molecules are broken down inside the membrane-enclosed vesicles. Malfunctions can lead to neurodegenerative diseases such as Parkinson's.
8 hours ago
0
35
Dual therapy shows promise for childhood brain cancer
Researchers at the Children's Cancer Institute and UNSW Sydney have tested a new way of treating childhood brain cancer by combining two medicines in lab studies. They found using the two treatments together may work better ...
9 hours ago
0
0
Scientists discover natural 'brake' that could stop harmful inflammation
Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide.
12 hours ago
0
74
FDA-cleared brain stimulation device for ADHD is not effective, new clinical trial finds
A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.
12 hours ago
0
40
Oral drug can safely lower triglycerides and other blood lipids, clinical trial finds
When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides. Triglycerides are a form of fat or lipid, which the body stores away into its fat cells as an energy fuel ...
7 hours ago
0
95
Asthma-related depression may be biologically distinct from primary depression
Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who experience symptoms of depression have elevated blood levels of a protein called brain-derived neurotrophic ...
8 hours ago
0
0
Research reveals clues as to why standard antidepressants fail for so many
A study from the University of Sydney's Brain and Mind Center reveals new clues as to why standard antidepressants fail for many Australians, opening the door for more effective, personalized treatments.
4 hours ago
0
12
Simulations predict antibody drug viscosity, paving way for easier self-injection
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick up the medicine every few weeks. It would be easier for them to be able to inject the medicine themselves ...
6 hours ago
0
0
Parenthood 'inoculates' adults against disgust, new study reveals
From diaper changes to nursing care, exposure to unpleasant substances is a daily reality for millions of people, but how does the brain adapt? New research from neuroscientists at the University of Bristol reveals that repeated, ...
22 hours ago
0
70
Study finds high blood pressure primes heart for damage from cancer drugs
Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than 30 years. Their extraordinary efficacy against numerous solid and hematologic tumors means that they ...
21 hours ago
0
0
What a study of 67,000 people reveals about sexual desire and age
Sexual desire is a fundamental part of being human and a driving force in many relationships, yet we still don't fully understand why it varies so much from person to person.
Altered microbiome: Oral bacteria play a role in chronic liver disease, study reveals
Each year, more than two million people die from advanced chronic liver disease (ACLD). Previous research has linked gut microbiome disruptions to this condition and suggested that bacteria typically found in the mouth may ...
Jan 15, 2026
0
63
New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death
University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein can prevent neuron death caused by DNA damage and p53 activation in neurodegenerative diseases.
Jan 15, 2026
0
0
